(1)
Al Janaby, T.; Khelwatty, S.; Bagwan, I.; Abbassi-Ghadi, N.; Modjtahedi, H. Co-Expression of HER2 EGFRvIII CD44 and Claudin 18.2 CD109 As Novel Prognostic Indicators in Stomach Adenocarcinoma. World J Oncol 2025. https://doi.org/10.14740/wjon2552.